摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (1S,4S,5S,7R)-4-exo-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylate | 250137-95-2

中文名称
——
中文别名
——
英文名称
methyl (1S,4S,5S,7R)-4-exo-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylate
英文别名
methyl (1S,4S,5S,7R)-4-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-carboxylate
methyl (1S,4S,5S,7R)-4-exo-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylate化学式
CAS
250137-95-2
化学式
C14H17NO4
mdl
——
分子量
263.293
InChiKey
GSAYHKCTAQKSRZ-FMSGJZPZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    56.8
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (1S,4S,5S,7R)-4-exo-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylate盐酸 作用下, 以 二氯甲烷 为溶剂, 反应 72.0h, 生成 (1S,4S,5S,7R)-3-(9-fluorenylmethoxycarbonyl)-4-exo-benzyl-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylic acid
    参考文献:
    名称:
    Synthesis and Reactivity of Bicycles Derived from Tartaric Acid and α-Amino Acids:  A Novel Class of Conformationally Constrained Dipeptide Isosteres Based upon Enantiopure 3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic Acid
    摘要:
    3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic acids (named BTAa) derived from (R,R), (S,S)-, or meso-tartaric acid and natural (L), unnatural (D), or unusual alpha-amino acids are described as conformationally constrained dipeptide isosteres. The general strategy developed for their preparation has required the transformation of the amino acids into the corresponding N-benzylamino alcohols, followed by the PyBroP-promoted condensation with the monomethyl ester of the suitable 2,3-di-O-isopropylidenetartaric acid. Oxidation of the hydroxy group to aldheyde and subsequent acid-catalyzed trans-acetalization with the two hydroxy groups of the tartaric acid moiety provided 3-aza-2-oxo-6,8-dioxabicyclo [3.2.1] octane-7-carboxylic acid methyl esters [named BTAa(O)] in good yield and, in most cases, as single enantiopure diastereoisomers. This strategy has been applied to the preparation of BTAa(O) starting from (R,R)-, (S,S)-, or meso-tartaric acid and glycine, L- and D-phenylalanine, L- and D-alanine, and (+/-)-phenylglycine. In the cases of glycine, L- and D-phenylalanine, and L- and D-alanine, the selective reduction by BH3. DMS of the amide group succeeding to the cyclization step, or the reduction of both amide and ester functions followed by reoxidation of the hydroxy to carboxylic group, provided in good yield the 3-aza-3-benzyl-6,8-dioxabicyclo[3.2.1]-octane-7-carboxylic acids (or their methyl ester) BTAa, having the side chain of the amino acid precursors at position 4. The stability and rigidity of the bicyclic skeleton, the complete control of all the stereocenters, the possibility of introducing the side chains of L- or D-amino acids, and the demonstrated compatibility with the conditions required for solid-phase peptide synthesis make the BTAa compounds potential dipeptide isosteres useful for the synthesis of modified peptides.
    DOI:
    10.1021/jo9904967
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Reactivity of Bicycles Derived from Tartaric Acid and α-Amino Acids:  A Novel Class of Conformationally Constrained Dipeptide Isosteres Based upon Enantiopure 3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic Acid
    摘要:
    3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic acids (named BTAa) derived from (R,R), (S,S)-, or meso-tartaric acid and natural (L), unnatural (D), or unusual alpha-amino acids are described as conformationally constrained dipeptide isosteres. The general strategy developed for their preparation has required the transformation of the amino acids into the corresponding N-benzylamino alcohols, followed by the PyBroP-promoted condensation with the monomethyl ester of the suitable 2,3-di-O-isopropylidenetartaric acid. Oxidation of the hydroxy group to aldheyde and subsequent acid-catalyzed trans-acetalization with the two hydroxy groups of the tartaric acid moiety provided 3-aza-2-oxo-6,8-dioxabicyclo [3.2.1] octane-7-carboxylic acid methyl esters [named BTAa(O)] in good yield and, in most cases, as single enantiopure diastereoisomers. This strategy has been applied to the preparation of BTAa(O) starting from (R,R)-, (S,S)-, or meso-tartaric acid and glycine, L- and D-phenylalanine, L- and D-alanine, and (+/-)-phenylglycine. In the cases of glycine, L- and D-phenylalanine, and L- and D-alanine, the selective reduction by BH3. DMS of the amide group succeeding to the cyclization step, or the reduction of both amide and ester functions followed by reoxidation of the hydroxy to carboxylic group, provided in good yield the 3-aza-3-benzyl-6,8-dioxabicyclo[3.2.1]-octane-7-carboxylic acids (or their methyl ester) BTAa, having the side chain of the amino acid precursors at position 4. The stability and rigidity of the bicyclic skeleton, the complete control of all the stereocenters, the possibility of introducing the side chains of L- or D-amino acids, and the demonstrated compatibility with the conditions required for solid-phase peptide synthesis make the BTAa compounds potential dipeptide isosteres useful for the synthesis of modified peptides.
    DOI:
    10.1021/jo9904967
点击查看最新优质反应信息

文献信息

  • [EN] PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO NEUROTROPHINES<br/>[FR] COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE MALADIES ASSOCIEES AUX NEUROTROPHINES
    申请人:GUARNA ANTONIO
    公开号:WO2004000324A1
    公开(公告)日:2003-12-31
    The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo[3.2.1]octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I), (II) and (III) are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF), such as neurodegenerative diseases of central nervous system (CNS), acquired immundeficiency due to a reduced NGF biodisponibility, or morbous conditions in which the stimulus of neoangiogenesis process is convenient.
    本发明涉及包含作为活性化合物的3-aza-bicyclo[3.2.1]辛烷衍生物的药物制剂,其通用式为(I),以及其通用式为(II)和(III)的二聚体,作为人类神经营养因子的激动剂。因此,通式(I)、(II)和(III)的这些化合物对于治疗神经营养因子功能缺陷相关的疾病非常有用,尤其是神经生长因子(NGF)缺陷,例如中枢神经系统(CNS)的神经退行性疾病、由于NGF生物可用性降低而导致的获得性免疫缺陷,或者在其中新生血管生成过程的刺激是方便的病态条件。
  • Synthesis and Reactivity of Bicycles Derived from Tartaric Acid and α-Amino Acids:  A Novel Class of Conformationally Constrained Dipeptide Isosteres Based upon Enantiopure 3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic Acid
    作者:Antonio Guarna、Antonio Guidi、Fabrizio Machetti、Gloria Menchi、Ernesto G. Occhiato、Dina Scarpi、Sauro Sisi、Andrea Trabocchi
    DOI:10.1021/jo9904967
    日期:1999.10.1
    3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic acids (named BTAa) derived from (R,R), (S,S)-, or meso-tartaric acid and natural (L), unnatural (D), or unusual alpha-amino acids are described as conformationally constrained dipeptide isosteres. The general strategy developed for their preparation has required the transformation of the amino acids into the corresponding N-benzylamino alcohols, followed by the PyBroP-promoted condensation with the monomethyl ester of the suitable 2,3-di-O-isopropylidenetartaric acid. Oxidation of the hydroxy group to aldheyde and subsequent acid-catalyzed trans-acetalization with the two hydroxy groups of the tartaric acid moiety provided 3-aza-2-oxo-6,8-dioxabicyclo [3.2.1] octane-7-carboxylic acid methyl esters [named BTAa(O)] in good yield and, in most cases, as single enantiopure diastereoisomers. This strategy has been applied to the preparation of BTAa(O) starting from (R,R)-, (S,S)-, or meso-tartaric acid and glycine, L- and D-phenylalanine, L- and D-alanine, and (+/-)-phenylglycine. In the cases of glycine, L- and D-phenylalanine, and L- and D-alanine, the selective reduction by BH3. DMS of the amide group succeeding to the cyclization step, or the reduction of both amide and ester functions followed by reoxidation of the hydroxy to carboxylic group, provided in good yield the 3-aza-3-benzyl-6,8-dioxabicyclo[3.2.1]-octane-7-carboxylic acids (or their methyl ester) BTAa, having the side chain of the amino acid precursors at position 4. The stability and rigidity of the bicyclic skeleton, the complete control of all the stereocenters, the possibility of introducing the side chains of L- or D-amino acids, and the demonstrated compatibility with the conditions required for solid-phase peptide synthesis make the BTAa compounds potential dipeptide isosteres useful for the synthesis of modified peptides.
查看更多

同类化合物

鸠麻霉素 阿孙病毒素 莨菪灵 网状链丝菌素硫酸盐 箭毒蛙毒素A 盐酸高吗啉 环丙基-(5,8,8-三甲基-9-氧杂-3-氮杂双环[3.2.2]壬烷-3-基)甲酮 嘧啶并[1,6-c][1,3]氧氮杂卓 咪唑并[2,1-b][1,3]氧氮杂卓 叔-丁基6-(氨基甲基)-1,4-噁吖庚环-4-甲酸基酯 [1,4]氧杂氮杂环庚烷-6-醇 [1,3]恶唑并[3,4-a]环氧乙烷并[d]吡啶 [1,2,4]恶二唑并[4,3-d][1,4]氧氮杂卓 N-BOC-1,4-高吗啉-6-羧酸甲酯 N-(4-甲基-1,5-二氧代-5A,6,7,8-四氢吡咯并[1,2-c][1,3]氧氮杂卓-3-基)己酰胺 9,11-裂-3,6,11-三羟基-24-亚甲基胆甾-7-烯-9-酮 7-氧杂-2-氮杂三环[4.3.0.02,5]壬烷 6-甲基-1,4-噁吖庚环盐酸 6-氧杂-1-氮杂双环[5.2.0]壬-3-烯 6-氧杂-1-氮杂双环[3.2.1]辛-3-烯-7-酮 6-亚甲基-1,4-高吗啉-4-甲酸叔丁酯 6-(羟甲基)-1,4-高吗啉-4-羧酸叔丁酯 5-甲基-7-(2'-(2''-甲基丙酰氧基)-3'-乙酰氧基)丁亚基-1a,2,3,7-四氢环戊烯并(b)环氧乙烷并(C)吡啶 5-甲基-7-(2'-(2''-甲基丁酰氧基)-3'-乙酰氧基)丁亚基-1a,2,3,7-四氢环戊烯并(b)环氧乙烷并(C)吡啶 5-叔-丁基-6,8-二氧杂-3-氮杂双环(3.2.1)辛烷盐酸盐 5-(3-吡啶基)-6,8-二氧杂-3-氮杂双环(3.2.1)辛烷二盐酸盐 5,9-二氧杂-2-氮杂三环[6.2.1.02,6]十一碳-1(10),3,6-三烯 5,8,8-三甲基-9-氧杂-3-氮杂双环[3.2.2]壬烷 5,7,7-三甲基-6-氧杂-3-氮杂三环(3.2.2.0)壬烷 4-氨基-1,4-氧代氮杂-6-胺 4-氧杂-2-氮杂三环[4.4.0.02,8]癸-1(10),5,8-三烯 4-叔丁氧羰基-6-氧代-1,4-氧氮杂庚环 4-乙酰基-2-氧杂-4-氮杂双环[3.2.0]庚烷-3-酮 4-Boc-6-氨基-1,4-噁氮杂烷 4-Boc-2-羟甲基高吗啉 4-BOC-[1,4]氧杂氮杂环庚烷-6-羟基 4-BOC-6-氨基-1,4-高吗啉盐酸盐 4-BOC-2-高吗啉甲酸乙酯 4-(三氟乙酰基)-1,4-氧杂氮杂环庚烷-7-酮 3-甲基-N-(4-甲基-1,5-二氧代-5A,6,7,8-四氢吡咯并[1,2-c][1,3]氧氮杂卓-3-基)丁酰胺 3-氧杂-7-氮杂双环[4.1.0]庚烷 3-吡啶甲硫醇,2-氨基- 3-乙基-5,8,8-三甲基-9-氧杂-3-氮杂双环[3.2.2]壬烷 3-(环丙基甲基)-5,8,8-三甲基-9-氧杂-3-氮杂双环[3.2.2]壬烷 3,7,7-三甲基-4,8-二氢-[1,2]恶唑并[4,5-d][1,3]氧氮杂卓-5-酮 3,7,7-三甲基-4,8-二氢-2H-吡唑并[4,3-d][1,3]氧氮杂卓-5-酮 3,5,9-三氧杂-10-氮杂三环[6.2.1.02,6]十一碳-1(10),2(6),7-三烯 3,5,9,11-四氧杂-8-氮杂三环[5.3.1.02,6]十一碳-1(10),2(6),7-三烯 3,5,10-三氧杂-9-氮杂三环[6.2.1.02,6]十一碳-1,6,8-三烯 3,4-二氢-7-甲基-1,4-氧氮杂卓-5(2H)-酮